Pharos iBio Co., Ltd. (KOSDAQ: 388870)
South Korea
· Delayed Price · Currency is KRW 8,090.00
+70.00 (0.87%)
Jan 21, 2025, 9:00 AM KST
Pharos iBio Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
104.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 300.00M | 243.00M | 426.32% |
| Dec 31, 2021 | 57.00M | -130.68M | -69.63% |
| Dec 31, 2020 | 187.68M | -233.43M | -55.43% |
| Dec 31, 2019 | 421.11M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 292.86T |
| SK hynix | 57.73T |
| LG Energy Solution | 27.17T |
| Samsung Biologics Co.,Ltd. | 4,364.39B |
| Hyundai Motor Company | 170.28T |
| Kia Corporation | 104.63T |
| Celltrion | 2,876.25B |
| KB Financial Group | 14.11T |